Appriss® acquires NARxCHECK™ from the National Association Boards of Pharmacy Foundation

LOUISVILLE, Ky., Nov. 11, 2014 /PRNewswire/ -- Appriss Inc., a leading technology provider for risk assessment and analytics, announced it has acquired NARxCHECK™ from the National Association Boards of Pharmacy Foundation (NABPF) to automate prescription drug abuse assessment and management through patented analytics. Developed by an emergency room physician and in collaboration with hospital associations, state pharmacy boards, NABPF, an affiliate the National Association of Boards of Pharmacy (NABP), and others, NARxCHECK can quickly identify those patients who may be at heightened risk for misuse of controlled substances. The technology supports practitioners by accessing patient prescription information from prescription drug monitoring programs (PMP), analyzing the data, and providing a risk-based score to assist practitioners in their health care decision-making.

The acquisition of NARxCHECK (http://www.narxcheck.com) unifies the family of PMP services Appriss provides in partnership with NABP including PMP InterConnect – the interstate PMP data sharing service, PMP Gateway, a health IT connectivity solution to deliver PMP data to health IT  and pharmacy IT systems, and NARxCHECK, a risk analytics solution to assess patient risk.

"This acquisition is a natural next step as Appriss works to deliver innovative clinical decision support technology to improve patient safety and curb the epidemic of prescription drug abuse. The partnership with NABP has delivered tremendous national progress over the past two years and we are now positioned to deliver significantly positive outcomes throughout the healthcare ecosystem," said Mike Davis, CEO of Appriss. Data provided in this secure solution will not only provide assistance when making decisions to restrict medication access due to suspected abuse, but also help ensure that those who legitimately need controlled substances can receive them without hesitation from physicians. 

"The Appriss team is well-equipped to deliver NARxCHECK to the healthcare community through  hospitals, pharmacies, health IT companies and other healthcare connectivity companies. NABP is pleased to continue working with Appriss on solutions that will assist healthcare practitioners and pharmacists with the identification and prevention of  prescription drug abuse," stated Carmen A. Catizone, MS, RPh, DPh, NABP Executive Director/Secretary.

NARxCHECK's capabilities, in an emergency room environment, were showcased in the InnovatED portion of the American College of Emergency Physicians (ACEP) Annual Scientific Sessions in Chicago last week, along with 50 other cutting-edge technologies in the emergency medicine industry. 

About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies to deliver solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss is always backed by customer support with technical support agents in the U.S. – 24x7x365.
For more information, visit www.appriss.com.

The National Association of Boards of Pharmacy (NABP)
The National Association of Boards of Pharmacy® (NABP®) was founded in 1904 and represents all of the pharmacy regulatory and licensing jurisdictions in the United States, eight provinces of Canada, Australia, and New Zealand. NABP is an independent, international, and impartial association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform pharmacy standards.
For more information, visit www.nabp.net.

SOURCE Appriss